α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.
about
Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body DisordersMitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons.α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP productionCholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?Protein misfolding in neurodegenerative diseases: implications and strategies.Sideroflexin 3 is an α-synuclein-dependent mitochondrial protein that regulates synaptic morphology.Lumbee traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.α-Synuclein and Parkinsonism: Updates and Future Perspectives.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Resveratrol and Brain Mitochondria: a Review.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's diseaseTop Altmetric Scores in the Parkinson's Disease LiteratureαSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.Progress toward an integrated understanding of Parkinson's disease.Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease.Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy.A functional connection between dyskerin and energy metabolism.Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease.Oxidative stress and cellular pathologies in Parkinson's disease.Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.Superoxide is the critical driver of DOPAL autoxidation, lysyl adduct formation, and crosslinking of α-synuclein.Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson's disease models.Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy.Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in C. elegans Models of Parkinson's Disease.β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein.An in vitro model yields 'importin' new insights into chronic traumatic encephalopathy: damaged astrocytes stop 'thrombospondin' to the injury: An Editorial Highlight for 'Defective synthesis and release of astrocytic thrombospondin-1 mediates the nIn Situ Proximity Ligation Assay Reveals Co-Localization of Alpha-Synuclein and SNARE Proteins in Murine Primary Neurons.Current perspective of mitochondrial biology in Parkinson's disease.Reactive oxygen species stress increases accumulation of tyrosyl-DNA phsosphodiesterase 1 within mitochondria.Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice.
P2860
Q28067429-7EF285A2-34DD-4B97-95FF-A7BD373F3699Q33364885-D217508C-2960-48FA-973E-96B99D586A01Q33617563-40DC2386-6BDB-4A18-AF96-0A2CA6223D4BQ33841149-138F71B6-F1B2-4425-8404-BC1EF717DA81Q36272936-58456227-91A8-4E6C-A5AA-31EA397D075CQ37635610-DFEA70AE-7B6B-4613-8DEE-01F505295D66Q37697832-2EAEE9D5-B376-4948-BA29-3CF976473F3EQ38438454-51CC94BA-36FE-4B7B-9ED3-2E2125FFA1B7Q38715902-B9A5F616-CF31-4243-ACA7-27AD30BC43EBQ38742153-2E35C137-5283-43F0-8CFD-F95BF0938372Q39052041-BE459BF3-5B22-4C10-BCDD-ED05CA22C561Q39173672-ABF68A80-A345-44AD-A8A0-6B81A9407BA5Q39205712-D764CC2C-9F3C-40EB-A089-8728ADEC402FQ40445564-AF327BFF-14C5-4449-93B8-BFFC2AFDE40BQ40986110-7B97F8E6-66C4-41DE-BB65-4E4265407430Q41012014-6FC7075B-9D9E-4972-85FF-65BB906AA6BAQ41308603-DA6D25A5-E36C-45FC-A1BE-16F6DD7ECDF0Q41664833-C70BF797-0A37-43C2-8F92-8FC9B58EE93CQ42096504-07E107D0-EAAD-4565-AECE-A6E8F753B242Q45218312-B63D49B6-E0E1-4782-BF42-D819A1441A94Q45435691-2EC9C89D-1661-4661-A9AC-E8F1115A17DEQ46252606-164B9FA2-ACAF-464D-B0C6-52BCEECCE319Q46349223-54CC7B1D-5412-409C-9D61-D0EAEDAA9103Q46382550-C62D6314-B31B-428E-AE08-C2BCBA9065D8Q47147993-0652E7CC-B415-4C1A-B54A-D13519531B1DQ47151554-764A7B7B-0881-42C9-AE34-84D47D0EBC6BQ47239603-8A943BBB-D87A-40EE-9D3A-77433E894FCCQ47348189-65B49AEE-5667-46AF-B4BD-4D5AC482342AQ47372795-D581DBF9-3F48-4EB4-81A0-01FC10FEA242Q47653685-CC268BD2-E749-4FE3-B6F6-901E4B44FF25Q47655102-4AD655F2-5E64-434A-9BE3-D3176C56393FQ48131649-2FD35728-1BD4-4F06-9EC9-CFCE664E36B3Q50338475-E385053A-6B32-4135-8852-31AA548D014BQ51200996-D5F43AC2-B482-40EF-BB4B-F3C612EFDD9EQ52330497-91E8D26A-5910-4F05-8DEA-79F8839F7D9BQ52351688-028F808E-0106-4D19-BD5E-78F8C1BA441AQ52361042-9065A22F-EB53-4EAF-A46E-40FDAA4675D4Q52591608-AF14938C-BCFA-4794-B6DF-DB485C83E63CQ52624714-841ECB2B-36F2-4D53-AF09-8CE75C79515CQ54986684-139F1436-9A37-4BEB-86D4-99EF801CC2BB
P2860
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
α-Synuclein binds to TOM20 and ...... import in Parkinson's disease.
@en
α-Synuclein binds to TOM20 and ...... import in Parkinson's disease.
@nl
type
label
α-Synuclein binds to TOM20 and ...... import in Parkinson's disease.
@en
α-Synuclein binds to TOM20 and ...... import in Parkinson's disease.
@nl
prefLabel
α-Synuclein binds to TOM20 and ...... import in Parkinson's disease.
@en
α-Synuclein binds to TOM20 and ...... import in Parkinson's disease.
@nl
P2093
P2860
P50
P921
P1476
α-Synuclein binds to TOM20 and ...... import in Parkinson's disease.
@en
P2093
Alevtina Zharikov
Caitlyn W Barrett
Eric K Hoffman
J Timothy Greenamyre
Jennifer McCoy
Paul J Barrett
Roberto Di Maio
Teresa G Hastings
Xiaoping Hu
P2860
P304
P356
10.1126/SCITRANSLMED.AAF3634
P407
P577
2016-06-01T00:00:00Z